Cosmo Pharmaceuticals N.V. (LON: 0RGI)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	939	763	900	895	1,018	874
Market Cap Growth	53.15%	-15.23%	0.57%	-12.08%	16.39%	-16.84%
Enterprise Value	831	727	864	864	956	736
Last Close Price	58.60	46.53	52.75	49.58	65.57	55.92
PE Ratio	15.92	-	58.91	49.16	-	-
PS Ratio	6.31	9.48	9.94	16.37	18.64	16.51
PB Ratio	2.31	2.05	2.19	2.08	2.84	2.62
P/TBV Ratio	11.69	20.67	14.08	9.52	2.87	2.78
P/FCF Ratio	10.25	29.04	35.34	149.55	128.14	-
P/OCF Ratio	9.96	26.15	30.54	84.48	87.48	-
EV/Sales Ratio	5.21	9.03	9.54	15.80	17.50	13.89
EV/EBITDA Ratio	9.59	42.51	23.65	57.74	176.12	-
EV/EBIT Ratio	11.22	136.27	34.71	92.64	590.89	-
EV/FCF Ratio	8.60	27.66	33.92	144.35	120.31	-
Debt / Equity Ratio	0.00	0.00	0.37	0.33	0.42	0.42
Debt / EBITDA Ratio	0.01	0.09	4.14	9.20	24.49	-
Debt / FCF Ratio	0.01	0.06	6.05	23.85	18.97	-
Asset Turnover	0.27	0.14	0.13	0.09	0.10	0.10
Inventory Turnover	3.19	3.06	3.29	3.50	4.66	4.97
Quick Ratio	4.35	3.15	1.45	11.77	11.06	18.39
Current Ratio	4.85	3.98	1.57	12.99	11.60	19.25
Return on Equity (ROE)	14.80%	-1.06%	3.59%	4.75%	-1.99%	-5.84%
Return on Assets (ROA)	7.82%	0.58%	2.24%	0.99%	0.19%	-1.27%
Return on Capital (ROIC)	9.59%	0.72%	2.66%	1.11%	0.20%	-1.32%
Earnings Yield	6.28%	-0.56%	1.70%	2.03%	-0.70%	-2.37%
FCF Yield	10.29%	3.44%	2.83%	0.67%	0.78%	-2.04%
Dividend Yield	2.84%	3.73%	1.77%	1.61%	-	-
Payout Ratio	6.07%	-	90.61%	-	-	-
Buyback Yield / Dilution	0.77%	1.95%	2.83%	-16.81%	1.11%	2.48%
Total Shareholder Return	0.77%	5.68%	4.60%	-15.20%	1.11%	2.48%

Source: S&P Capital IQ. Standard template. Financial Sources.